Abstract Marine microbes are capable of producing secondary metabolites for defense and competition. Factors exerting an impact on secondary metabolite production of microbial communities included bioactive natural products and co-culturing. These external influences may have practical applications such as increased yields or the generation of new metabolites from otherwise silent genes in addition to reducing or limiting the production of undesirable metabolites. In this paper, we discuss the metabolic profiles of a marine Pseudomonas aeruginosa in the presence of a number of potential chemical epigenetic regulators, adjusting carbon sources and co-culturing with other microbes to induce a competitive response. As a result of these stressors certain groups of antibiotics or antimalarial agents were increased most notably when treating P. aeruginosa with sceptrin and co-culturing with another Pseudomonas sp. An interesting cross-talking event between these two Pseudomonas species when cultured together and exposed to sceptrin was observed.
Introduction
Marine microbes are capable of producing distinct secondary metabolite profiles based on their need for defense, competition, or a number of other environmental factors [1] . The biosynthesis of active metabolites from microbes can be economical and environmentally friendly, hence the discovery of bioactive substances from microbes is appealing to the pharmaceutical and agrochemical industries as a whole. The most common approach for discovery of bioactive secondary metabolites from microbes is screening microbes for biological activities. However, a major challenge to this approach is the cultivation of microbes under laboratory conditions. Even under the best of circumstances, these experiments fail to emulate environmental conditions such as competition, diverse nutrient sources, extreme temperature variations, and other epigenetic factors. The result is an artificial environment for producing secondary metabolites which may cause the silencing of certain genetic pathways. To address this problem, strategies of using stimuli were utilized to more closely mimic the natural environment under potential stressful conditions. Under specific stresses, microbes can respond to stimuli, thus increasing the yield of certain secondary metabolites or producing new metabolites. Cichewicz's research group identified several new metabolites by treating the fungus Cladosporium cladosporioides with histone deacetylase or DNA methyltransferase inhibitors [2] . This study provided evidence that the ecological responses could be attributed to the chemical activation of gene expression corresponding to the secondary metabolite biosynthetic gene clusters. While many epigenetic studies focus on direct DNA methylation inhibitors, other chemical stressors, such as antibiotics, can induce an epigenetic response [3] . Fenical's research group reported an increased production of emericellamides A and B when co-culturing the fungus Emericella sp. with an actinomycete Salinispora arenicola [4] . In this case, biochemical communication between microorganisms represents more complicated interactions in microbial communities. These interactions resulting in the change of metabolic production in live microbial colonies and communities can be visualized today using MS imaging and chemical networking [5] .
In 2009, marine sediment microbes were collected from the Texas Gulf Coast. Based on general antimicrobial and antimalarial activities screening of their extracts, 17 antibiotic producing microbes were identified. From one of the microbes, YPD1C, which was characterized as Pseudomonas aeruginosa, seven rhamnolipids, two derivatives of phenazine and six 2-alkyl-4-quinolones were isolated. This isolation allowed us to understand the metabolic profile of biologically active secondary metabolites from P. aeruginosa, and provided the basis for comparison to identify the differences in metabolite production when treating P. aeruginosa with different modifiers and external stimuli. In the world of bacteria, stimuli can change bacterial metabolic profiles by affecting DNA methylation [6] , transcription initiation [7] , quorum sensing [8] , kinase signaling [9] or carbon and nitrogen metabolism [10] . In this paper, impacts on antibiotic production of P. aeruginosa were discussed using potential epigenetic modifiers including kinase inhibitors manzamine A, kahalalide F, and sceptrin, a cell transport regulator ilimaquinone; adjustment to growth factors such as carbon sources and temperature or co-culturing with four other antibiotic producing microbes (YPD1A, YPD1D, YPD5A, and YPD5C) also collected from the Gulf of Mexico in the fall of 2009. Interestingly, an improvement of antibiotic production was observed in a mixed microbial community with the presence of the chemical modifier sceptrin.
Methods

Microbial Collection and Isolation
On October 24, 2009, a sediment collection was made in a tributary leading into West Galveston Bay (N29 13.349°W 95 12.992°). Sediment was collected from the bay floor using a Petite Ponar grabber and scooped into a 50 mL conical tube. The volume of collected sediment was diluted with sterile filtered artificial sea water (Instant Ocean, following the manufacturer's instructions) to approximately 1.5 times the original volume. The sediment was mixed by agitation and heat shocked at 55°C for 8 min. The sample was allowed to rest until the sediment had settled. Volumes of 300 and 150 μL of supernatant were platted on Yeast Peptone Dextrose (10/20/20 g/L, YPD) media with 50 μg/mL of ampicillin. The microbes were allowed to grow at room temperature until colonies appeared. Once colonies grew, individual colonies were chosen and streaked onto secondary plates containing no antibiotics, but still supplemented with 2 % Instant Ocean. These microbes were again grown at room temperature until colonies appeared. Using these plates, pure colonies were isolated and glycerol stocked at −80°C for preservation and large-scale growth.
16S rRNA YPD1A, YPD1C, YPD1D, YPD5A, and YPD5C were grown in supplemented YPD media at 30°C and 200 rpm overnight. DNA was isolated using MoBio Ultrapure DNA purification system and following the manufacturer's instructions. 16 s DNA was amplified by PCR using the published 17f and 1492r universal bacteria 16 s primers. The resulting amplified DNA was cloned into the pCR2.1 vector using a topoTA (Invitrogen) ligation kit. Plasmids were purified and subsequently sequenced using the T7 and M13 sites in pCR2.1. Analysis was conducted by comparison of acquired sequences of the five microorganisms with NCBI's BLAST.
Large-Scale Growth and Extraction
Eight cultures of YPD1C isolate (500 mL per each) were grown using YPD media supplemented with 2 % Instant Ocean in 2.5 L Fernbach flasks incubated at 30°C and 250 rpm for 7 days. The cultures were sonicated for 20 min and then centrifuged for 10 min at 3600 rpm in 250 mL portions. The supernatant was decanted into a flask and the cell pellet was discarded. Approximately 160 mL of HP-20 resin was added to the supernatant. The flask was again placed in the incubator and left overnight at 30°C and 250 rpm.
The HP-20 resin was extracted using a Buchner funnel. The media was discarded. The HP-20 was treated with 1 L of EtOH followed by 500 mL of EtOAc and extractions were dried under vacuum. The extracts were assayed to assess biological activity.
Compound Isolation
The EtOH extract of YPD1C cultures (20 
Treatments of P. aeruginosa (YPD1C)
YPD1C was cultured at different temperatures with different carbon sources (glucose, sodium acetate, oil mix, starch, and citric acid), nitrogen sources (NH 4 Cl, NaNO 3 , NaNO 2 , urea, and peptone), chemical regulators (sceptrin, kahalalide F, manzamine A, and ilimaquinone) and co-cultured with the four other antibiotic producing microbes (YPD1A, YPD1D, YPD5A, and YPD5C). Considering the extensive number of experiments required, an orthogonal design was used to minimize the sample size. Each sample was processed in duplicate (SI- Table 1 ). Cultures of the YPD1C isolate (50 mL) were grown using different media supplemented with 2 % Instant Ocean mix in 250 mL flasks incubated at 15-45°C and 250 rpm for 3-7 days. YPD1C grown in YPD media at 30°C and 250 rpm for 7 days was used as a positive control, while four regulators prepared in YPD media respectively were used as negative controls. Prior to harvest an OD 600 value was recorded to compare biomass. All the cultures were sonicated for 20 min and centrifuged for 10 min at 3,600 rpm. The supernatant was extracted with 100 mL of EtOAc (×3). The organic layers were combined for further bioassays and fingerprint analysis.
Fingerprint Setup of Each Extract
Each extract was dissolved in 5 mL MeOH and filtered. The volume of 10 μL of each sample was eluted on a C8 column (4.6 mm×250 mm, 5 μm) using a gradient of MeOH (with 0.05 % HCOOH)-H 2 O (with 0.05 % HCOOH) from 40:60 to 100:0 over 45 min at flow rate of 0.6 mL/min. A TOF-MS detector was used to acquire fingerprints on positive mode. A fingerprint of each extract was compared.
Disc Diffusion Assay
Disc Diffusion Assay (DDA) provided a rapid and reliable method to screen fractions during purification. A concentration limitation experiment was performed with each active extract to determine the minimal amount needed to observe a zone of inhibition. This minimal amount of each column fraction was added to a 6 mm filter paper disc. Bacillus cereus cells suspended in water (no more than 250 μL) were evenly plated onto antibiotic media 2 (Difco). The discs were added to the plate with a control of 50 μg of kanamycin and allowed to grow at 30°C overnight. Activity was determined as a clear zone of inhibition. Relative activity between fractions could be determined based on the radius of inhibition.
Antimicrobial Assay
All organisms were obtained from the American Type Culture Collection (Manassas, VA) and included the fungi Candida albicans ATCC 90028, Candida glabrata ATCC 90030, Candida krusei ATCC 6258, Cryptococcus neoformans ATCC 90113, Aspergillus fumigatus ATCC 204305, and the bacteria Staphylococcus aureus ATCC 29213, methicillin-resistant S.
aureus ATCC 33591 (MRSA), Escherichia coli ATCC 35218, and Mycobacterium intracellulare ATCC 23068. Susceptibility testing was performed using a modified version of the CLSI (formerly NCCLS) methods. M. intracellulare was tested using a modified method. Samples were serially diluted in 20 % DMSO/saline and transferred in duplicate to 96 well flat-bottom microplates. Microbial inocula were prepared by correcting the OD 630 of microbe suspensions in the incubation broth. DMSO was used as the negative control. Drug controls [ciprofloxacin (ICN Biomedicals, OH) for bacteria and amphotericin B (ICN Biomedicals, OH) for fungi] were included in each assay. All organisms were read at either 630 nm using the EL-340 Biokinetics Reader (Bio-Tek Instruments, Vermont) or 544ex/590em, (M. intracellulare) using the Polarstar Galaxy Plate Reader (BMG LabTechnologies, Germany) prior to and after incubation. Samples are tested in duplicate at one concentration (50 μg/mL) and percent inhibitions are calculated relative to blank and growth controls. Samples showing ≥50 % inhibition in at least one test organism are selected for dose response (secondary) studies at 20, 4 and 0.8 μg/mL. If samples from the secondary assay showing an IC 50 of <2 are retested in duplicate at 50, 10, 2, 0.4, 0.08, 0.016 μg/mL.
Antimalarial Assay
Antimalarial activity was determined in vitro against chloroquine sensitive (D6, Sierra Leone) and resistant (W2, Indo China) strains of Plasmodium falciparum by measuring plasmodial LDH activity. Chloroquine and artemisinin were used as the positive controls. Test compounds were dissolved in DMSO (2 mg/mL). A 200 μL suspension of P. falciparum culture (2 % parasitemia and 2 % hematocrit in RPMI 1640 medium supplemented with 10 % human serum and 60 μg/mL amikacin) was added to the 96-well plate containing 10 μL of serially diluted samples. The plate was flushed with a gas mixture of 90 % N 2 , 5 % O 2 , and 5 % CO 2 and incubated at 37°C for 72 h in a modular incubation chamber. Plasmodial LDH activity was determined by using Malstat™ reagent (Flow Inc., Portland, OR) [11] . The incubation mixture (20 μL) was mixed with 100 μL of the Malstat™ reagent and incubated for 30 min. A 1:1 mixture of NBT/PES (Sigma, St. Louis, MO) (20 μL) was then added, and the plate was further incubated for 1 h in the dark. The reaction was stopped by adding 100 μL of a 5 % acetic acid solution. The plate was read at 650 nm. The in vitro cytotoxicity to mammalian cells (Vero cells) was also tested to determine the selectivity index of antimalarial activity of compounds. Cells were seeded at a density of 25,000 cells/well and incubated for 24 h. Serially diluted samples were added and incubated for 48 h. The number of viable cells was determined by Neutral Red assay [12] . Doxorubicin was used as a positive control. IC 50 values were obtained from dose response curves.
Results
Identification of Active Compounds
Biological evaluation revealed that fractions 3, 4, and 6 (hexanes-EtOAc 50:50, 25:75, and EtOAc-MeOH 75:25, respectively) inhibit growth of B. cereus (SI- Fig. 1 ) in DDA. Further purification yielded 15 known compounds (Fig. 1) . Fractions 3 and 4 were purified by HPLC yielding two characterized active compounds 1-phenazine-carboxamide (1, SI- Fig. 2 ) and 1-phenazinecarboxylic acid (2, SI- Fig. 3 ). Fraction 6 was eluted using LH-20 with DCM-MeOH (50:50) producing 10 sub-fractions, in which Fr6-4, Fr6-6 and Fr6-7 were active in the B. cereus DDA. Fr6-4 was further purified by HPLC, yielding six pure compounds. Fr6-4-7-6 was identified as 2-heptyl-4(1H)-quinolone (3, SI- Fig. 4 ) using LC-MS, 1 H, 13 C, and HMBC NMR spectra. Structures of the remaining five compounds were determined to be known compounds 1-hydroxy-2-heptyl-4-quinolone (4, SI- Fig. 5 ), 2-Octyl-4(1H)-quinolone (5, SI- Fig. 6 ) and 2-nonyl-4(1H)-quinolone (6, SI- Fig. 7 ), 2-(2-nonenyl)-4(1H)-quinolone (7, SI- Fig. 8) , and 2-(1-nonenyl)-4(1H)-quinolone (8, SI- Fig. 9 ) using LC-MS and HMQC overlay experiments. Further isolations of Fr6-6 and Fr6-7 were conducted using a C8 (250 mm×10 mm, 5um) column to yield seven known rhamnolipids: Rha-C 10 -C 10 (9, SI- Fig. 10 ), Rha-Rha-C 10 -C 10 (10, SI- Fig. 11 ), Rha-Rha-C 10 -C 12:1 ( 11, SI-Fig 12) , Rha-Rha-C 10 -C 12 (12, SI-Fig 13) , Rha-C 10 -C 12:1 (13, SI-Fig 14) , Rha-C 10 -C 12 (14, SI-Fig 15) , Rha-C 8 -C 10 (15, SI- Fig 16) . Two D-rhamnose and two α-hydroxy fatty acid moieties were identified by comparing characteristic spin systems from the 1D and 2D 1 H COSY spectra and optical rotation values with the literature [13, 14] .
Activities of Isolated Compounds
Compounds 1-3, 6, and 8-15 were submitted for antimicrobial and antimalarial activities ( ND IC 50 was not tested due to less than 50 % of inhibition was observed in the primary assays cytotoxicity against Vero cells. This was the first report regarding antimalarial activity of these molecules. The potency and safety of 6 and 8 suggest a favorable potential in treating malaria.
Identification of Microorganisms
BLAST analysis demonstrated YPD1C was 99 % identical to P. aeruginosa. YPD1A and YPD1D were determined to be unique Bacillus sp., YPD5A and YPD5C were two Pseudomonas sp..
Activities of Extracts Under Different Treatments
Extract activity was normalized by comparison with the activity of the regulator control in each bioassay and comparing the OD 600 values to account for biomass, thus providing an accurate assessment. Direct sum in an orthogonal design was used to determine the best condition for each modifying factor.
As a result, the best condition to produce antimicrobial compounds was oil mix (50 % corn oil, 50 % olive oil) as the carbon source, peptone as a nitrogen source, and incubation at 30°C for 11 days (SI- Table 2 ). However, extracts under most conditions were less active when compared to positive control. Interestingly, when treating YPD1C with sceptrin or coculturing with YPD5A, the best antimalarial activity was observed. Treatments with manzamine A, kahalaide F, and ilimiquinone proved to inhibit growth in initial experiments and were not further pursued. YPD5A produced the most significant result in co-culture experiment and the focus shifted to co-culture with this strain.
To further determine the significance of sceptrin and YPD5A on the antibiotic production from YPD1C, a second batch of experiments was designed using YPD media, at 30°C and 250 rpm for 7 days, different concentration of sceptrin, with/without YPD5A. OD 600 values were measured to test viability of the microbe in each condition and give a ND IC 50 was not tested due to less than 10 % of inhibition was observed in the primary assay. relative biomass between experiments. Antimicrobial and antimalarial activities were tested for all the extracts (Table 2) . Extracts from YPD5A (T7-T9) did not have antimicrobial and antimalarial activities, while extracts with the presence of YPD1C (T1-T3, T5-T6) displayed activities in all assays. The activity data (T1-T6) was analyzed with analysis of variance (ANOVA). As a result, all the activities showed significant difference between conditions (P < 0.01). To further determine which treatment was responsible for the major difference, a Dunnett's test was applied by comparison of treatment groups (T2-T6) with a positive control group (T1). In the groups singly treated with sceptrin or coculturing (T2, T3 in all activities, and T4 in antimicrobial activities), there was no significance observed (P>0.05). However, when treating sceptrin and co-culturing with YPD5A, a significant enhancement of all activities was observed (T5, P<0.05; T6, P<0.01; Figs. 2 and 3) . The antimicrobial activities of YPD5A (T7-T9) decreased significantly when adding 5 μM sceptrin (T9, P<0.05). Meanwhile, the OD 600 value of T9 dropped more than five times and was equivalent to media controls. It was unclear if this decline was due to a bacteriostatic or a bacteriocidal effect; however, at 1 μM there was no effect on growth. This lack of growth would also result in lack of antibiotic production.
The total ion chromatograms (TICs) of YPD5A extracts (T7-T9) displayed different profiles from those of YPD1C extracts (Figs. 4 and 5) . The MS analysis confirmed that YPD5A did not produce the same active metabolites as YPD1C. This remained consistent with the activity result presented above. The TICs of T1, T5, and T6 showed an increase in secondary metabolite production, especially phenazines (Rt 10-15 min) and quinolones (Rt 18-26 min) (Fig. 5) . To further determine the variation of each class of metabolites, extracted ion chromatograms (EICs) were compared by extracting ions at m/z=224, 225, 244, 260, 270, 272 (Fig. 6) , 651, 505, 677, 679, 531, and 533 (Fig. 7) corresponding to compounds 1, 2, 3, 4, 7, 8, 6, 10, 9, 11, 12, 13, and 14, respectively. It was noticed that the yield of compounds 1, 2, 3, 4, 6, 8, 11, 12, and 14 increased in T5 and T6. Moreover, metabolites in quinolones area (Rt 18-26 min) with m/z=298 displayed a high intensity. Based on the MS data and retention time, it could contain two more methylenes than compound 7 or 8. Some other signals need to be further identified. According to the activities, compounds 1, 2, 11, and 12 were responsible for the antifungal activity, compounds 1, 8, and 14 for the antibacterial activity, while compounds 3, 6, and 8 for the antimalarial activity. The comparison of fingerprints complemented the observed bioactivity and our statistical analysis. 
Discussion
Role of Yeast Extract in Media
As the result of orthogonal experimentation, the best condition to produce antimicrobial compounds was oil mix (50 % corn oil, 50 % olive oil) as the carbon source, and peptone as a nitrogen source. However, antibiotic production under the given condition was far less than that of YPD medium. YPD consists of yeast extract, peptone, and dextrose, among which only yeast extract was not added during the media modifications. Hence, we propose that one or more components of yeast extract play a key role in the high yield of antibiotic production. Yeast extract is a processed by extracting yeast cell contents. There was evidence that small RNAs from yeast extract present in media could change bacterial protein profiles, thus influencing bacterial adaption [15] . Yeast extract may serve both as a nutrient in growth media in addition to a stimulus for P. aeruginosa, thus inducing antibiotic production; however, due to the complex nature of yeast extract it was not added to maintain control of the media constitution.
Roles of Regulators
Epigenetic refers to heritable changes from parent to progeny. In bacteria, DNA methylation is a major component of epigenetic inheritance and induction of the changes is invoked by use of methylase inhibitors [6] . There is potential for other stressing molecules, such as antibiotics, to also induce heritable changes in the phenotype [3] . The potential of kinase inhibitors was tested in this experiment using marine natural products. Manzamine A has been identified as a potent GSK-3β inhibitor [16] . Kahalalide F was shown to down-regulate the ErbB3 and inhibit Akt signaling [17] . Both of these compounds are cytotoxic. When the regulator controls were tested, both manzamine A and kahalalide F displayed inhibition on all microbes. Cultures treated with manzamine A and kahalalide F lacked growth during fermentation, indicating that the compounds were cytotoxic to the bacteria. At non-inhibitory concentrations these may induce an epigenetic response.
Sceptrin has diverse activities including antifungal, antibacterial, and antihistaminic. It has shown to be an inhibitor of somatostatin and cell motility [18] . Based on our experimental data, the addition of sceptrin does not have a significant influence on YPD1C. However, it does affect the vitality of another Pseudomonas sp., YPD5A. The fingerprint comparison of T7-T9 suggested a different metabolic profile after treating with 5 μM sceptrin (Fig. 5 ). These could be degradation products of sceptrin or other metabolites released from YPD5A as part of a stress induced stringent response. The data indicated that YPD5A was able to trigger a series of responses in YPD1C under stress conditions [19] . The exact mechanism of this interaction is unclear and includes potential cross talk between microbes, recognition of cellular components of lysed YPD5A, and degradation of sceptrin.
Mixed Fermentation
Usually, microbes within the same genus are able to consume the same nutrients for their survival. When co-culturing, there could be potential competition for nutrients [20, 21] . In our experiment, another Pseudomonas sp., YPD5A, was cocultured with YPD1C. A comparison of activities as well as OD 600 values between T1 and T4 suggested the vitality of both YPD1C and YPD5A were weakened after co-culturing due to an insufficient of nutrient.
Chemical communications between microbes can induce a series of interactions between species. The data clearly indicated that YPD1C co-cultured with only sceptrin or YPD5A was not sufficient to equal the results of culturing all three components together. We have also established that the concentration used in this co-culture was sufficient to inhibit growth of YPD5A. This suggests several possible roles in the co-culture. One option is that YPD5A released a signaling molecule when exposed to 5 μM sceptrin and this molecule induces production of secondary metabolites in YPD1C. Another option is a much more complex crosstalk mechanism between the two stains involving a combination of quorum sensing molecules and sceptrin or derivatives thereof. Modulation of quorum sensing (QS) in P. aeruginosa has been well studied. Natural products such as tobramycin [22] and lyngbyoic acid [23] were reported as regulators of QS signaling. Quinolones have been implicated in QS regulation [24] . An increase in OD 600 as well as quinolone concentration implied a relationship between the antibiotic production of the species and microbial competition between species.
